Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2020; 10(5): 135-141


In silico and in vitro cytotoxicity profile of hydroalcoholic extract/fraction(s) of Pachygone ovata

Jeswiny Rodrigues, Kiran Kumar Hullatti, Pukar Khanal.




Abstract
Cited by 4 Articles

Medicinal plants have been used in the past for the treatment of diseases and continue to be an important reservoir for the development of new drugs. With the increasing burden of cancer globally, there is a need to find newer anticancer agents. The process of identification and evaluation of cytotoxic molecules from plants can be achieved conveniently by using simple yet reliable screening models and combining with in silico techniques. Pachygone ovata, least explored plant from Menispermaceae family, is known to be rich in alkaloids. This study aimed to identify the cytotoxic constituents from Pachygone ovata through bioactivity-guided fractionation using Brine shrimp lethality bioassay as a screening model. The active fraction in this assay was evaluated for its in vitro cytotoxic activity on human tumor cell lines. Some reported alkaloids were studied for their binding affinities with topoisomerase II by molecular docking. The study revealed the cytotoxic constituents from P. ovata. The study also revealed alkaloids with higher binding affinity with topoisomerase II, and the scope for further use leads to the development of new drugs.

Key words: Bisbenzylisoquinoline, Brine shrimp, Menispermaceae, MTT, Topoisomerase






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.